ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Other Current Assets
ADC Therapeutics SA
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Other Current Assets
$16.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Other Current Assets
CHf6.4m
|
CAGR 3-Years
17%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Current Assets
$14.4m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Current Assets
CHf7.7m
|
CAGR 3-Years
42%
|
CAGR 5-Years
35%
|
CAGR 10-Years
4%
|
|
Idorsia Ltd
SIX:IDIA
|
Other Current Assets
CHf34.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Other Current Assets
CHf513k
|
CAGR 3-Years
-43%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Other Current Assets?
Other Current Assets
16.3m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Other Current Assets amounts to 16.3m USD.
What is ADC Therapeutics SA's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
59%
Over the last year, the Other Current Assets growth was -39%. The average annual Other Current Assets growth rates for ADC Therapeutics SA have been 18% over the past three years , 59% over the past five years .